Investment and M&A Opportunities in HEALTHCARE Conference - NASHVILLE

About Our Executive Speaking Faculty:


	Donald A. Adam, SVP & Chief Development Officer, RehabCare Group, Inc. St. Louis, MO Don Adam was named Chief Development Officer for RehabCare (RHB:NYSE) in August 2007; prior to that time, Don served as RehabCare’s Senior Vice President of Mergers & Acquisitions. In his role, he is responsible for the advancement of RehabCare’s corporate vision through the identification and negotiation of strategic joint venture partnerships, mergers, acquisitions, or other combinations with health care systems and providers throughout the post-acute continuum of care. Don is also a member of RehabCare’s Executive Management Team, which is comprised of the senior officers of the organization; the EMT meets monthly to develop and implement the strategic direction for RehabCare and its subsidiaries. In addition to Development, Don is among the team responsible for managing the Company’s relationships with its investment & corporate bankers, equity analysts, and institutional investors. Before joining RehabCare in 1999, he enjoyed a successful career in Banking. He holds a Bachelor’s Degree in Finance from Penn State, and a MBA from the University of Pittsburgh.

	Rami Armon, Vice President, Avalere Health LLC (Washington DC) Washington, DC Rami Armon, Vice President, advises Avalere clients on the impact that legislative, regulatory, judicial, and policy changes have on the healthcare industry. He has extensive experience in the analysis of public policy and healthcare reform. Rami previously served as the Health Care Policy Analyst and Chief Political Strategist at Lehman Brothers where he led the analysis of the activities of various U.S. government bodies and their impact across healthcare services, managed care, distribution, and life sciences companies. Rami has taught health policy at the Wharton School’s Executive Education Program, and led policy courses for five years at Harvard, where he was awarded for his teaching excellence. Rami is a Phi Beta Kappa graduate of Harvard College with an honors B.A. in Government, and a graduate of Columbia University’ School of International & Public Affairs with an M.A. In addition, he holds an honors J.D. from Harvard Law School and an M.A. in History from Harvard’s Graduate School of Arts & Sciences.

	Perry Ballard, Principal, Flexpoint Ford Chicago, IL Mr. Ballard is a Principal of Flexpoint Ford, an industry focused private equity firm dedicated to the healthcare and financial services sectors. Prior to joining Flexpoint Ford, Mr. Ballard served as a Vice President of GTCR Golder Rauner. Prior to joining GTCR, Mr. Ballard began his career in investment banking at Credit Suisse First Boston. Mr. Ballard received a B.A. in Economics, with highest distinction and honors, from the University of Michigan and an MBA from Harvard Business School.

	Samuel "Bo" Bartholomew, Founder & CEO, PharmMD Solutions Nashville, TN Samuel “Bo” Bartholomew, III, is an experienced healthcare executive having served as founder of eMedical, LLC, as managing partner of Integration Ventures, LLC and associate administrator for Centennial Medical Center and StoneCrest Medical Center with HCA. As part of the StoneCrest Executive Team, he led efforts to build a $100 million state-of-the-art hospital on time and under budget. Now serving as President, CEO and a founder of medication therapy management provider PharmMD, Bartholomew is leading the growth and development of the company as it offers services and products with a team of clinical and IT experts from around the country to lives in all 50 states. As President, CEO and a founder, Bartholomew has led PharmMD through rapid growth over the past four years with several rounds of funding and a nationwide expansion of services. PharmMD is a medication therapy management (MTM) company serving large employers and health plans. PharmMD manages the appropriate use of medications to improve the health of the individual and manage employers’ pharmacy costs. 1/4th of all Emergency Rooms visits in the nation can be attributed to prescription related medication errors. Employers and health plans are seeing their drugs costs rise while at the same time covering the costs of the mis-managed medications causing their medical claims to rise. MTM can help lower these numbers. The Centers for Medicare & Medicaid Services (CMS) included a definition of MTM in its 2006 document. CMS now dictates that each Part D Sponsor is required to incorporate a MTM program into their plans' benefit structure. Bartholomew brings to his position as CEO a depth of expertise in healthcare. Prior to helping found PharmMD, Bartholomew has worked with health IT firms, hospitals, and disease management firms. Bartholomew adds a diverse perspective by bringing a military and a seminary background to what he does and he was trained in HCA’s Executive Development Program training the COO’s and CEO’s for HCA’s hospitals nationwide. Bartholomew currently serves as the Chairman of Leadership Healthcare representing over 500 members is fostering the next generation of healthcare leaders. He serves on the board of the Nashville Healthcare Council, the Tennessee Center for Bioethics and Culture, the Tennessee Red Cross. His four kids and wife, Sarah, are his most valued accomplishments in life.

	Gregory M. Browne, Managing Director, Healthcare Leveraged Finance, CAPITALSOURCE FINANCE LLC Chicago, IL As the Managing Director and head of the Healthcare Cash Flow Group at CapitalSource, Mr. Browne is responsible for originating and underwriting leveraged senior loans primarily to private equity owned companies in the healthcare sector. He oversees a portfolio of approximately $400 million in commitments to over 20 companies in various sectors within the healthcare industry. Prior to joining CapitalSource in 2003, Mr. Browne served as a Senior Vice President at GE Capital's Healthcare Financial Services group (formerly known as Heller Financial) where he spent eight years in various capacities including both cash flow lending and, to a lesser extent, asset based lending. During his tenure at GE Capital, Mr. Browne was one of the original members of their healthcare-focused, cash flow lending team which financed middle-market, private equity-sponsored transactions. Prior to GE Capital, Mr. Browne worked as a Group Vice President within the Special Assets division at Sanwa Business Credit Corporation. The division managed Sanwa's troubled asset portfolio which included both general industry and healthcare transactions. Prior to completing his first tenure at GE Capital between 1989 and 1991, Mr. Browne worked at Lloyds Bank for three years. He began his finance training at Chemical Bank where he completed the bank's credit training program and later joined the bank's Multinational Division which covered the Fortune 500 agriculture and construction equipment manufacturers.

	Michael S. Cole, Managing Director, Alvarez & Marsal Nashville, TN Michael Cole is a Managing Director and the Healthcare Industry Leader of Alvarez & Marsal Transaction Advisory Group. For more than 11 years, Mr. Cole has specialized in spearheading financial accounting healthcare due diligence projects for complex public and private company transactions. Mr. Cole has assisted numerous private equity firms and strategic buyers with transactions across a wide spectrum of healthcare and life sciences segments, including acute care hospitals, long-term care, home health, hospice, specialty and institutional pharmaceuticals, ambulatory surgical centers, clinical laboratories, physician and dental practices and clinics, pharmacy benefit management, managed care, disease management, contract research organizations and other healthcare service organizations. Mr. Cole specializes in providing accounting and transaction structuring advice, throughout the transaction lifecycle, assessing quality of earnings and key business and earnings drivers, as well as SEC and GAAP accounting and reporting requirements. He critiques financial models and purchase agreements and reviews the financial performance of target companies to identify cost reductions and / or operating efficiencies. He has worked with management teams of private equity-backed portfolio companies to complete add-on acquisitions and direct platform investments. Prior to joining A&M, Mr. Cole was a Partner and the National Leader of Private Equity - Healthcare at Ernst & Young. In this role, he led financial accounting due diligence projects for private equity investor groups and strategic buyers, and the development and coordination of the firm's go-to-market and service delivery strategies for private equity funds with healthcare interests. Previously, Mr. Cole was with the Audit & Business Advisory practice of Arthur Andersen in Nashville. Mr. Cole earned a bachelor's degree in accountancy, with high honors, from the University of Kentucky. He is a Certified Public Accountant (CPA) in Tennessee and Kentucky, and an active member of the American Institute of Certified Public Accountants (AICPA) and the Tennessee State Society of Certified Public Accountants (TSCPA). Mr. Cole is a founding member of Leadership Healthcare, a Nashville-based organization dedicated to fostering the next generation of healthcare leaders. He is a frequent guest lecturer on financial accounting due diligence at healthcare industry seminars.

	C. Taylor Cole, Jr., Partner, Charterhouse Group, Inc. New York, NY Mr. Cole joined Charterhouse Group in 1998 and has been a Partner of the firm since 2003. During that time, he has invested in a broad range of industries including healthcare, specialty distribution and consumer goods. Since 2001, Mr. Cole’s primary focus has been on the evaluation and execution of platform and add-on investments and on monitoring portfolio company activities, all within the Healthcare Services sector. Prior to joining Charterhouse, Mr Cole was a member of the Investment Banking Division of Morgan Stanley & Co. in New York and Hong Kong. While at Morgan Stanley, he was involved in a wide array of M&A transactions as well as public and private financings and recapitalizations. Mr. Cole currently serves as a member of the Board of Directors of The Camelot Schools, Chamberlin Edmonds & Associates, Cross Country Healthcare and Upstream Rehabilitation. Mr. Cole holds an M.B.A. from the Darden Graduate School of Business Administration at the University of Virginia and a B.A. from the University of Virginia.

	Michael (Trey) Alexander Crabb, III, MHA, MBA, Managing Principal, Stroudwater Associates Nashville, TN Trey Crabb has been a trusted advisor to clients in the healthcare industry for 19 years. He has extensive experience with both not-for-profit and for profit healthcare organizations in strategic advisory transactions as well as debt and equity capital raises. He joined Stroudwater Associates in October 2008 to head up the Firm’s Nashville, Tennessee, office. Prior experience includes positions as Managing Director and Co-Head of Healthcare Investment Banking at Avondale Partners, LLC (Nashville) and not-for-profit merger, acquisitions and affiliations investment banking at Merrill Lynch & Co. (New York; London). Mr. Crabb was a founding member of the healthcare corporate and investment banking group at Bank of America (Charlotte, North Carolina). His operational experience includes strategy and financing work at a privately-held anesthesia physician contract outsourcing company and strategic planning in the department of physical medicine and rehabilitation at a major academic medical center. Mr. Crabb lectures at the Gillings School of Global Public Health, University of North Carolina at Chapel Hill, the Owen Graduate School of Management, Vanderbilt University and in the graduate and undergraduate business programs at the University of Alabama where he was appointed to the Adjunct Faculty in 2009. He has been a regular featured speaker at a number of continuing education seminars across the U.S. on strategic transactions involving healthcare organizations. He is a member of the American College of Healthcare Executives, the Health Policy Issues Group and in 2008 he was a delegate in Sweden and Germany with the Nashville Health Care Council during its healthcare trade mission. Representative Accomplishments Trey's recent work has included: Representing for profit and not-for-profit healthcare organizations in divesting non-core assets in a wide variety of industry sectors Working with the private equity community in exploring a number of healthcare sub-sectors in which to invest its funds and executing those transactions Raising private capital on behalf of healthcare clients for acquisitions, recapitalizations and organic growth opportunities Advising not-for-profit clients on whole-hospital joint ventures, physician syndications, affiliations, mergers and acquisitions (buy-side and sell-side) Structuring and executing all manner of clinical service line partnership relationships between for profit and not-for-profit organizations Representing healthcare organizations in investing in technology-enabled solutions to help its businesses work more efficiently and profitably Education Mr. Crabb earned dual master’s degrees from the University of North Carolina at Chapel Hill. His master of healthcare administration was awarded by the Gillings School of Global Public Health (Foster G. McGaw Scholar, Delta Omega, Alpha Epsilon Lambda) and his master of business administration was awarded by the Kenan-Flagler Business School (Dean’s Scholar, Beta Gamma Sigma). He earned his B.S. in corporate finance and investment management at the University of Alabama, and until 2009 served his undergraduate alma mater as president of the 2,000 member Middle Tennessee Chapter of the University of Alabama Alumni Association. In 2006 and 2009, Mr. Crabb was elected to three year terms on the UNC School of Public Health’s Foundation Board and in 2008 he was elected chairman of the audit committee.

	Greg Crabtree, CEO, Crabtree, Rowe & Berger, P.C. Huntsville, AL Greg started his own firm in 1986 after having spent 5 years with a regional accounting firm and 3 years as VP of Operations/Controller for a local bank. Greg’s banking experience proved to be the background for the firm’s focus on financial modeling and data-driven decision analysis while still providing traditional tax and financial statements services. In addition to serving as CEO, Greg is the senior consultant for the firm. He specializes in helping both mature and emerging businesses develop systems and organizational structures to meet financial goals and priorities. This process allows firm clients to align their financial goals to be consistent with their profit model and their core business values. Greg and his team structure monitoring programs to help their clients stay on track and provide them financial analysis to verify if the changes are having a positive financial impact. Rather than focus on one particular industry, Greg searches for best practices among firm clients and other business sources to redistribute them across industry lines. Greg serves as board member to several companies as well as the ALS Association of Alabama, Boys and Girls Clubs of North Alabama, and the Atlanta Chapter of The Entrepreneurs' Organization. From 2006 to 2009, Greg was named to the Entrepreneurs' Organization Global Board and served as Chair of the Standing Finance Committee and board liaison to the Strategic Alliances Committee and the Technology Committee. Greg and his wife Debbie have four children (2 out of college, 2 in college). Greg is an avid golfer and enjoys playing historic golf courses whenever his travel plans permit.

	Dan Davidson, Healthcare Investment Banking, Morgan Joseph & Co., Inc. Atlanta, GA Dan Davidson is a Director with Morgan Joseph in the firm’s Healthcare Group. Mr. Davidson is actively involved in advising clients on mergers and acquisitions, recapitalizations, restructurings, in addition to delivering the firms financing capabilities. With 14 years of financing related experience, Mr. Davidson has initiated and completed a variety of transactions for financial sponsors and healthcare companies. During his career, he has completed in excess of 50 middle market transactions totaling approximately $9 billion of transactional value. Before joining Morgan Joseph, Mr. Davidson was a Senior Vice President with Jefferies & Company, Inc., where he served as a senior member of the firm’s Healthcare Group. Previously, Mr. Davidson held positions at CIT Healthcare, BNP Paribas and Wachovia Securities, where he was involved in the origination and execution of a variety of corporate and financial sponsor related transactions. Mr. Davidson served in the United States Marine Corps for 6 years, including service during the Persian Gulf War. He serves as President of the National Marine Corps Business Network, and is actively involved in advising and promoting the Patriot Guard. Mr. Davidson received a BS in finance from Clemson University.

	John Deane, CEO, Southwind Health Partners Nashville, TN John Deane is Founder and CEO of Southwind Health Partners®, a contract management, interim management and consulting company focused on improving the performance of physician practices owned by hospitals, health systems and academic medical centers. Southwind clients include many of the nation’s preeminent integrated health care delivery systems seeking to align with physicians through employment as well as information technology deployment and pay-for-performance managed care contracting strategies. Now in its 10th year, Southwind currently serves 50 clients in 25 states. The company is composed of 33 physician practice management executives working at the intersection of the hospital/physician relationship. John has over 20 years of senior physician practice management and managed care experience. He has led turn around engagements for a number of large, institutionally sponsored medical groups, facilitating annual savings from $2 to $20 million. In addition, he has consulted major health systems regarding physician alignment, leading engagements focused on strategic planning, physician compensation model design, practice acquisition, turn around restructuring and alternative models of physician alignment. Prior to founding Southwind, John served as an officer of a national physician practice management company, Executive Director of a faculty practice plan at the University of Texas Medical Branch at Galveston and Executive Director of a physician/hospital joint venture managed care enterprise at Washington University Medical Center in St. Louis. John began his career as a consultant with VHA Enterprises Consulting Services in Irving, Texas working on provider sponsored HMO’s, PPO’s and Physician/Hospital Organizations. John holds a BA in political science and MPA in public administration with distinction from The American University in Washington, D.C.

	Steven Elek, III, Partner-in-Charge, Healthcare Transaction Services, PricewaterhouseCoopers Philadelphia, PA Steven Elek, Partner, leads the Healthcare Practice in the Transaction Services Group of PricewaterhouseCoopers LLP. He is responsible for delivering a wide range of merger, acquisition, divestiture and corporate finance related services. Steve has over twenty-five years experience in a wide range of healthcare industry sectors that give him a broad understanding of the interrelationships amongst the sectors. His sector experience includes pharmaceutical/life sciences, health insurance/managed care, general acute-care hospitals, psychiatric hospitals, integrated delivery systems, long-term care, rehabilitation centers, home care, clinical laboratories and medical device manufacturers. Steve is an attorney and a Certified Public Accountant. He is a past President of the Association for Corporate Growth's Philadelphia Chapter and a past Chairman of its Board of Directors. He is a member of the HealthCare Financial Management Association, American Institute of Certified Public Accountants, Pennsylvania Institute of Certified Public Accountants, the Pennsylvania Bar Association and the Philadelphia Bar Association. Steve has been a frequent speaker and author on various acquisition, divestiture and financing topics.

	Craig Frances, M.D., Managing Partner, Summit Partners Palo Alto, CA Craig Frances, M.D. is a Managing Director in the Palo Alto office of Summit Partners, a private equity and venture capital firm that has raised more than $11 billion since inception. He leads healthcare investing on the West Coast. Craig’s recent investments include National Veterinary Associates, the largest private owner of free-standing veterinary hospitals in the United States; HealthCare Partners, the largest private physician group in California; and Physicians Formula, the largest and fastest growing, independent cosmetics manufacturer in the mass market. Prior to Summit, Craig was President of The .tv Corporation Int’l, acquired by Verisign (NASDAQ: VRSN); co-founder of yourPharmacy.com, a leading online pharmacy backed by Express Scripts; and co-founder of Expert Consensus Guidelines. Craig was Chief Medical Resident at the University of California, San Francisco and Valedictorian at Cornell Medical College. Craig’s board directorships and investments currently include HealthCare Partners and National Veterinary Associates. He previously held board or advisory posts with Commission Junction, HealthAllies, Medscape, and Physicians Formula.

	Gregg A. Gerken, Vice President Development, HCA Nashville, TN Gregg A. Gerken is Vice President of Development for HCA Inc., a $30 billion healthcare services company with businesses in 20 states and the United Kingdom. Gregg is responsible for the acquisition and divestiture of the company's hospitals and outpatient businesses, and has completed in excess of $3 billion in healthcare transactions during his 15-year tenure with HCA. In his current role, he is responsible for the management of a team of transaction professionals, the development and evaluation of the strategic rationale for transactions, the cultivation of counter-party relationships, the development of transaction valuations, the negotiation of purchase prices and terms, due diligence investigations, and federal and state regulatory approvals. His transaction experience includes general acute-care hospitals, ambulatory surgery centers, home health agencies, diagnostic imaging centers, rehabilitation facilities, psychiatric hospitals, skilled nursing facilities and clinical research organizations, both domestically and internationally. Gregg has over 23 years of experience in healthcare service companies. Prior to joining HCA, he was Controller at Ameristat Mobile Medical Services, Treasury Manager with EPIC Healthcare Group, and in financial roles at American Medical International.

	Russ Herakovich, Managing Director, GE Capital, Healthcare Financial Services Atlanta, GA Russ has over 15 years of experience structuring and syndicating leveraged cash flow and asset based senior credit facilities and over 11 years of experience covering the healthcare industry. He is responsible for a 5-person team, which originate debt transactions in the southeast and central regions. Russ joined GE Capital, Healthcare Financial Services in 2002 and previously served as Senior Vice President of sales in charge of the central region. From 1998 to 2002, he was a Director with SunTrust Robinson Humphrey’s Loan Syndications Structuring team and covered a wide variety of industries. From 1994 to 1998 Russ was with First Union Capital Markets’ (now Wachovia Securities/Wells Fargo) Healthcare Financial Services and Communications and Media Finance Teams. He began his professional career as a healthcare consultant with Andersen Consulting (now Accenture). Russ holds a Bachelor’s degree in Finance from Virginia Tech and a Master’s degree in Business Administration from the University of Virginia. He serves on Virginia Tech’s Pamplin College of Business Advisory Council. Russ currently resides in Atlanta with his wife and three sons. With over $23 billion invested exclusively in healthcare, GE is a premier provider of capital, financial solutions and services to the global healthcare markets. With a dedicated focus and a deep knowledge of the healthcare industry, GE Capital, Healthcare Financial Services collaborates with customers to create tailored financial solutions that help them improve their productivity and profitability. GE Capital, Healthcare Financial Services covers virtually every sector of the healthcare industry and the product offering includes term loans, revolving credit facilities, equity tag along investments, second lien placements, high yield placements, A/R securitizations, DIP financings and interest rate management. For more information, visit www.gehealthcarefinance.com.

	Harris Hyman, Senior Principal, Flexpoint Ford Chicago, IL Harris Hyman IV is a Senior Principal of Flexpoint Ford, an industry focused private equity firm dedicated to the healthcare and financial services sectors. Mr. Hyman focuses on investments in the healthcare sector and has over 20 years of experience working with healthcare companies. Prior to joining Flexpoint, Mr. Hyman was a General Partner at a middle market private equity firm, where he was responsible for the firm’s healthcare investment activity. Mr. Hyman previously was a Managing Director at Credit Suisse First Boston, where he served as Co-Head of Healthcare Mergers & Acquisitions. During his 19 years as an investment banker, Mr. Hyman served as financial advisor to many of the leading U.S. and European healthcare companies. Mr. Hyman serves on the board of directors of MedAssets, Inc. and United BioSource Corporation. He received a B.S.E., magna cum laude, from Princeton University and an M.B.A. from Harvard Business School.

	Brian Kerby, Partner, Transaction Services, Crowe Horwath LLP Chicago, IL Mr. Kerby is a Senior Manager in Crowe Horwath’s Financial Advisory Practice. He has eighteen years of healthcare industry experience in various aspects of audit and financial advisory services. He has extensive experience providing merger and acquisition services to strategic and financial buyers as well as specialty finance lenders in most sectors of the healthcare industry. Mr. Kerby has provided professional services to clients on acquisition and financing deals in the healthcare industry ranging in size from $10 million to in excess of $1 billion. Mr. Kerby’s services include due diligence investigations, management consulting, working capital analysis, and developing financial projections. He has led numerous projects for clients including private equity, specialty finance, and corporate strategic buyers. Prior to working on transaction service engagements, Mr. Kerby spent eight years performing financial statement audits, reimbursement consulting, and other financial advisory services within the healthcare industry. He also spent three years at Blue Cross and Blue Shield of Illinois where he performed audits of Medicare and Blue Cross provider cost reports in accordance with appropriate regulations. Mr.Kerby is a member of the American Institute of Certified Public Accountants and the Illinois CPA Society. He graduated from Ball State University with a Bachelor of Science, Accountancy.

	Christopher W. Kersey, MD MBA, Managing Member & Partner, Camden Partners Baltimore, MD Dr. Kersey serves as a Managing Partner of Camden Partners in Baltimore, Maryland, where he focuses on private equity investments in the health care and life science industries. Founded in 1995, Camden Partners is one of the largest growth equity and investment management funds in the United States with more than $700 million under management. Dr. Kersey’s current health care and life science portfolio companies include LipoScience Inc. and PetDrx Corporation (NASDAQ: VETS), and his previous portfolio companies included MedServe Inc. (acquired by Stericycle Corporation, NASDAQ: SCRL), ComView Medical Systems (acquired by Evolved Digital Systems, TSX: EVD), Targacept Corporation (NASDAQ: TRGT), AlgoRx Pharmaceuticals (NASDAQ: ANSV), Rejuvenon Corporation (acquired by Helsinn Healthcare S.A.), Xeotron Inc. (acquired by Life Technologies Corporation, NASDAQ: LIFE) and Macrogenics Inc. Dr. Kersey has served in a variety of community, civic and professional organizations throughout his career, including as President of the Houston Private Equity Association and Foundation Board Director at the Memorial Hermann Healthcare System, one of the nation’s largest not-for-profit health care systems. A Phi Beta Kappa, Truman Scholar and Presidential Scholar graduate of Stanford University, Dr. Kersey graduated summa cum laude as the Class of 1996 Valedictorian at the Emory University School of Medicine. In 1996, Dr. Kersey attained the distinction of becoming the first individual in history to be accepted in the same year into the residency program of Harvard Medical School as well as Harvard Law School and Harvard Business School, where he later graduated as the Class of 1998 Walter Fellow as one of the School’s first medical doctors. A teammate of Pete Sampras on the Prince High School All-American Tennis Team and a former professional tennis player, Dr. Kersey lives in Maryland with his wife Johannah and daughter Arrabella.

	Joné L. Koford, President, Strategic Growth and Development, LifePoint Hospitals® Nashville, TN Joné Law Koford, President of Strategic Growth and Development for LifePoint Hospitals®, oversees the Company’s efforts to pursue strategic acquisitions and implement in-market growth and development initiatives for the Company’s facilities nationwide. LifePoint Hospitals, based in Brentwood, Tennessee, is a leading hospital company affiliated with 47 hospitals in 17 states. Koford joined LifePoint Hospitals in 2001 as Vice President of Development. Prior to assuming her current role, she served as President of Strategic Growth and Quality Initiatives, overseeing hospital strategic planning, capital asset management, the physician resource initiative and in-market development, as well as clinical operations and quality initiatives. Previously, from 2001 to 2007, she served as Division President for the American Division, overseeing 10 hospitals. Prior to joining LifePoint, Koford served as Vice President with Altius Health Plans in Salt Lake City, Utah, and Regional Vice President for both Columbia/HCA and HealthTrust in Nashville. She holds a master’s degree in science and health administration from the University of Colorado and is a graduate of Weber State University, where she serves on the National Advisory Council.

	Mark A. Kromkowski, Partner, McGuire Woods LLP Chicago, IL Mr. Kromkowski has represented investment funds and portfolio companies in all types of private equity and corporate transactions from venture to mezzanine to buyout transactions. He has developed a substantial practice in the areas of complex financings, mergers and acquisitions, and general corporate representation for private and public companies. Selected Representative Matters Represented more than 100 venture capital, mezzanine, buyout, and real estate private equity funds in their formation, fundraising and administration. Provided regulatory guidance with respect to portfolio company investments and related issues to numerous regulated private equity funds including SBIC Funds. Honors and Professional Affiliations AV Rated, Martindale-Hubbell (Highest Rating) Institutional Investors Committee, American Bar Association (ABA) Association for Corporate Growth (ACG) National Association of Small Business Investment Companies (NASBIC) Illinois Venture Capital Association (IVCA) Education University of Notre Dame Law School, South Bend, Indiana, J.D., 1998 University of Notre Dame, South Bend, Indiana, B.A., cum laude, 1992

	Burk Lindsey, Managing Director, Health Care Investment Banking, Raymond James & Associates Nashville, TN Burk Lindsey is a Managing Director in the Health Care Investment Banking Group of Raymond James & Associates. Mr. Lindsey advises on mergers and acquisitions and public and private financings for health care services companies. He leads the Firm’s efforts in the behavioral health, managed care, and post-acute sectors. Post-acute companies include those in the home health, hospice, skilled nursing, rehabilitation and long-term acute care sectors. He joined Raymond James in 2001; prior to joining the Firm, he held investment banking and merchant banking positions with SunTrust Equitable Securities and ING Barings, respectively, focusing on the health care services industry with both firms. He has an MBA degree in Finance and Taxation from Emory University.

	Mohamad H. Makhzoumi, Principal, New Enterprise Associates Menlo Park, CA Mohamad joined NEA in 2005 and is a Principal focused on venture capital and growth equity investments in the healthcare services and healthcare information technology arenas. He serves on the Board of Directors for American Pathology Partners, Elements Behavioral Health and Simplex Diabetic Supply while also being involved with NEA’s investments in Bravo Health, CHG Healthcare Services and Vantage Oncology. Prior to joining NEA, Mohamad was an Associate with Summit Partners, where he was one of fifty professionals responsible for investing and managing over $5.5 billion in capital. Mohamad focused on growth equity investments ranging from $15 – $300 million, including Summit’s investment in Global Cash Access (NYSE: GCA). Previously, Mohamad was an Associate with UBS Investment Bank where he was a member of the UBS Los Angeles office focused on leveraged finance, healthcare and financial sponsors’ coverage. Mohamad received a bachelor's degree, with distinction, in International Relations and Economics from the University of Pennsylvania.

	Kevin McCarty, Managing Director, West Monroe Partners Chicago, IL Kevin McCarty is the co-founder of West Monroe Partners, a 250-person business and technology consultancy formed in early 2002 as a spin-off of Andersen. Kevin currently is the Managing Director of West Monroe Partners’ Chicago Office, our largest and most established office. Applying more than 15 years of global business and technology experience, Kevin’s market-facing role is in leading the company’s Merger & Acquisition (M&A) practice. Kevin and the West Monroe Partners M&A team have executed more than 250 transaction-related projects including IT and operational due diligence and post-close integration services related to technology and business processes, many of which have been in Healthcare – the most active sector for West Monroe’s M&A services since 2007. *Highlights* Kevin McCarty is a solutions-oriented executive who combines business acumen and technology expertise to strategize, design, develop, and deliver high impact results for clients. Kevin has personally served more than 200 clients throughout his professional consulting career, most of which have been Private Equity Firms and their mid-market target and portfolio companies where critical investments are being made and high growth is the expectation. Kevin currently leads West Monroe Partners’ Merger & Acquisition practice (approximately 25% of the firm’s overall annual revenue), which focuses on M&A transaction-inspired business transformation, business process optimization, packaged software selection and implementation, business intelligence, and IT due diligence and post-close integration. Kevin exclusively serves clients in advisory, implementation, and management capacities for investors, boards of directors, and key C-level executes including CEO, CFO, COO, and CIO levels. He leads teams that specialize in critical transformational initiatives, such as post-close integration or carve-outs, large investment business and technology change initiatives, and troubled project recovery. He has guided the evolution of West Monroe Partners’ capabilities in this area from a collection of services to an integrated set of solutions designed to empower executives by facilitating the processes, systems, tools, and resources they need to drive better business results. Today, under Kevin’s leadership, West Monroe Partners maintains a team of highly experienced business and technology consultants who work with clients across a broad range of industries and deliver deep expertise in banking & insurance, capital markets & trading, energy & utilities, healthcare & life sciences, manufacturing & distribution (including food & beverage, consumer packaged goods). Throughout his consulting career, Kevin has led innovative projects for some of the largest global companies and non-profit associations. His current focus is on working with middle-market businesses – typically ranging from $100 million to $2 billion in revenue – and high potential entrepreneurial start-ups, spin-offs, or incubators. Accordingly, Kevin’s expertise is sought nationwide by strategic and financial buyers, including leading private equity and venture capital organizations. Kevin spends a substantial portion of his time conducting due diligence to advise these organizations on the IT and business process implications of potential investments. He then leads the execution of mergers and acquisitions, carve outs, divestitures, and integrations of businesses into a platform or under a holding company. He has led IT and operational diligence and post-close transition work for more than 250 M&A deals over the past 8 years. Experienced across many industries, Kevin's business strategy, process, and systems depth is best exhibited by his work with information- and data-rich organizations, as well as businesses with transaction-intensive operations such as those in the insurance, capital markets, and trading industries. He has worked with high-profile health plans and payors, as well as some of the world’s largest retail and mail-order pharmacies, to optimize vital systems and processes. From a technology perspective, Kevin is an accomplished information technology executive and enterprise architect who combines software engineering, data management, connectivity and infrastructure, usability, and IT process expertise to deliver business change and results. Kevin's commitment to client service is well recognized and thoroughly documented with impressive client satisfaction surveys and testimonials. In addition to providing trusted business advisor and technology architect services, Kevin has also served as an expert witness for numerous intellectual property litigation and patent infringement cases involving issues of software engineering and trade theft. Kevin co-founded West Monroe Partners in 2002 to deliver expertise and solutions in a way that is uniquely suited to the needs of growing organizations. Previously, Kevin spent eight years with Arthur Andersen in Chicago as senior manager and director of Pervasive Computing, Wireless, and Infrastructure for the firm’s Business Consulting practice. Prior to joining Andersen, Kevin gained the foundation of his technical depth in infrastructure and software development through various other technology product and services organizations. Kevin is a member of the Executives’ Club of Chicago, where he is active in the Young Leaders mentoring program; the Association for Corporate Growth, an organization that focuses on merger and acquisition and industry trends for corporate and private equity investing; and America’s Health Insurance Plans (AHIP), a trade association addressing the needs of health insurance plans and payors. He is also a patron of the Chicago Goodman Theatre and the YMCA of Metropolitan Chicago. He has published articles in a variety of industry publications and is sought as a subject matter expert on business and technology topics in healthcare, pharmacy, and mergers and acquisitions. Kevin received his Bachelor of Science in Business Administration and Management of Information Systems from the University of Illinois, Champaign-Urbana.

	Chris McFadden, Managing Director, Health Evolution Partners New York, NY Chris McFadden is responsible for all aspects of investment and portfolio management activities in the Growth and Buyout Fund at Health Evolution Partners. He has over twelve years of health care industry experience as a research analyst and investor. Mr. McFadden joined Health Evolution partners from Goldman Sachs & Co. Mr. McFadden joined Goldman Sachs in 1999 as a vice president and was named managing director in 2004. He most recently directed debt and equity investments for in private and public North American-based healthcare companies as part of Goldman Sachs’ Americas Special Situations Group. From 1999 to 2007, Mr. McFadden was a senior equity analyst responsible for Goldman Sachs’ US healthcare services research coverage and served as a member of the Global Investment Research Sounding Board. Prior to joining Goldman Sachs, Mr. McFadden worked as a senior research analyst at Wheat First Securities, now Wachovia Securities. Prior to that, he held marketing and management positions at Xerox Corporation. Mr. McFadden earned a BA in political science from the University of Richmond and studied graduate economics at Virginia Commonwealth University. Mr. McFadden became a Chartered Financial Analyst (CFA) in 1999. Mr. McFadden serves as a member of the board of trustees of Montefiore Medical Center in New York. He founded and leads RAMP, a mentor program for undergraduate students and is the past chairman of the advisory board for the Philip Coltoff Center of the Children’s Aid Society. He is also a fellow for the Health Care Solutions Group of Nashville.

	J. Carter McNabb, Managing Director, River Cities Capital Funds Cincinnati, OH Carter McNabb joined River Cities Capital Funds in 1999 and leads the firm’s healthcare investing practice with concentration on technology-enabled healthcare service companies and medical devices. While at River Cities, Carter has led and participated in fourteen healthcare investments, including successful exits with Suros Surgical Systems, National Medical Solutions, CMHC Systems, Foresight Corp and Health Personnel Options. He currently serves as Director on the boards of Health Integrated, AcceleCare Wound Centers, Inspiris, PerfectServe, OrthoHelix Surgical Designs, OrthoScan, Horizon Resource Group and NICO Corp. Prior to joining River Cities, Carter worked in equity research at J.C. Bradford & Co., a leading regional investment bank now part of UBS. He began his career in marketing and business development for Home Technology Healthcare, a comprehensive home healthcare company offering nursing, DME, infusion therapy and hospice across the southeast. Home Technology Healthcare was private equity financed by the Bank Fund and acquired by Integrated Health Services in 1997. Carter received his MBA from Vanderbilt University where he was recipient of the Bradford Fellowship for achievements in corporate finance. He completed his undergraduate studies at Trinity College in Hartford, CT.

	Brian Miller, Partner, Linden LLC Chicago, IL Brian Miller is a Partner and Co-Founder of Linden Capital Partners, a Chicago-based healthcare and life science focused private equity fund. Prior to Linden, Brian was a founding member of the healthcare and life science team at First Chicago Equity Capital. Mr. Miller began his career in the investment banking division of Salomon Brothers Inc (currently Citigroup). He is a board member of BarrierSafe Solutions International, CORPAK MedSystems, and Suture Express. Mr. Miller holds a Bachelor of Arts with honors in Economics from Princeton University and an MBA from Harvard Business School, with a concentration in healthcare. He is an officer of the Harvard Business School Health Industry Alumni Association, a founder of Private Equity Analysts of Chicago, and a member of the Alumni Board of the Latin School of Chicago. Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated investing and operating expertise, and iii) strategic relationships with large corporations. Linden’s portfolio includes BarrierSafe Solutions International, Behavioral Centers of America, Corpak MedSystems, Drayer Physical Therapy Institute, Focused Health Solutions, Ranir, and Suture Express. For additional information, please visit www.lindenllc.com.

	Jeffrey C. Nahley, Managing Director, Healthcare Investment Banking, Signal Hill Capital Group LLC Mr. Nahley has over 20 years of investment banking experience concentrated in the Healthcare, Business Services and Government Outsourcing sectors. Jeff has completed more than 100 transactions and engagements during the course of his career, including initial public offerings, follow-on and secondary equity offerings; high yield bond transactions and private placements of debt and equity; fairness opinions in connection with public mergers and acquisitions (M&A), as well as M&A buy-side, sell-side and unsolicited takeover representation. Prior to joining Signal Hill, Jeff was a Founder, Board Member and Head of the Investment Banking Group with Avondale Partners, LLC since the firm’s inception in 2001. During Jeff’s tenure as Head of Investment Banking, Avondale completed approximately 120 investment banking transactions and assignments approaching $11 Billion of value. In addition, Jeff was responsible for developing Avondale’s Investment Banking industry coverage practices; the firm’s M&A, Private Capital, and Public Offering product groups; and managed his own “book” of Healthcare, Business Services and Government Outsourcing clients and transactions. Jeff completed approximately 50 transactions and assignments exceeding $5 Billion of value while with Avondale. In 2006, Jeff was named to the Nashville Business Journal’s Healthcare 100. From 2000 to 2001, Jeff was a Managing Director with ING Barings’ Investment Banking Group focusing on Business Services and Healthcare; from 1993 to 2000, Mr. Nahley was an investment banker with Equitable Securities and managed the firm’s Government Outsourcing investment banking practice. Jeff started his career with Bankers Trust in 1986 where he spent 7 years focused on structured financings and M&A. Mr. Nahley received his BA from Middlebury College in 1986 and an MBA from Columbia Business School in 1991.

	Jon Santemma, Managing Director, Global Healthcare Group, Jefferies & Company, Inc. New York, NY Jon is a Managing Director in the Jefferies Healthcare Investment Banking Group with responsibility for Healthcare Services. Jon’s primary focus is on providers, specifically hospitals and the alternate site spectrum, including long term care, assisted living, home care, rehabilitation and related areas. In addition, Jon has responsibility for healthcare REITS. Prior to Jon joining Jefferies in 2009, Jon was a Managing Director with UBS Global Healthcare Group which he joined in 1999. From 1995- 1999, Jon was a Senior Healthcare Services Banker at Citigroup. Prior to that, Jon was a merger and acquisitions attorney with the New York law firm Skadden Arps Slate Meagher and Flom. From 1999-2004 Jon was based in London, with responsibility for European specialty pharmaceuticals and healthcare services. Jon holds a JD/MBA from Fordham University and a BA from Hamilton College. Jon’s US transaction experience includes: $1.1 bn take-private financing for United Surgical Partners, $300mm Medical Properties Trust acquisition bridge financing for a HCP hospital portfolio, $555mm sale of Lifecare Hospitals to Carlyle, $1.9bn take-private of Genesis Healthcare, $400mm financing of Amedisys Inc.’s acquisition of TLC Home Care, and $625mm sale of Harborside Healthcare of Sun Healthcare. Jon’s European healthcare services experience includes: $920mm sale of United Surgical European Hospitals, $4 billion sale of General Healthcare Group to Apax Partners and the $1 billion acquisition by Blackstone of NHP.

	George A. Smith II, Partner, Maynard, Cooper & Gale, P. C. Huntsville, AL GEORGE A. SMITH II is a Partner in the Huntsville office of Maynard, Cooper & Gale, P.C., where his practice focuses on formation, financing and ongoing representation of emerging and established businesses, with an emphasis on government contracting, healthcare and technology companies. Mr. Smith also counsels clients regarding tax issues, equity and debt financing, mergers and acquisitions and other transitions in ownership, executive compensation, joint ventures, strategic alliances, estate planning, healthcare and other related issues. Mr. Smith previously served as a Law Clerk for the Honorable Irene F. Scott, Senior Judge, U.S. Tax Court, (1992-1994). Mr. Smith is a 1991 graduate of the University of Alabama School of Law and received an L.L.M. in Taxation from New York University in 1992. Mr. Smith received his B.S. Degree in Accounting from Lipscomb University in 1988.

	Ryan Stewart, Senior Principal, Triple Tree, LLC Minneapolis, MN Ryan Stewart joined TripleTree in mid-2009 as a Senior Principal, bringing more than 15 years of extensive banking and operational experience to the firm's Healthcare practice. Previously, Ryan was a senior healthcare services banker with Lazard, with lead responsibility for the firm’s healthcare technology and care management practice. Prior to Lazard, Ryan was a corporate strategy executive at UnitedHealth Group; Managing Director and Senior Healthcare Equity Research Analyst at Piper Jaffray; and Founder/CEO of a venture-backed HCIT company and healthcare strategy and operations consultant with Arthur Andersen. Ryan began his career in Business Development with Horizon BlueCross BlueShield of New Jersey. Ryan has a B.A. in Government & Law from Lafayette College in Easton, PA.

	Marvelle Sullivan, Head of Corporate Legal M&A, Novartis International, AG Basel, Switzerland Marvelle Sullivan is the Head of Corporate Legal M&A at Novartis, having joined the company in March 2007. In this role, she is responsible for legal aspects of M&A transaction evaluation and execution at Novartis, as well as head of the company's M&A Practice Group. During Ms. Sullivan's time at Novartis, the company has been very active in M&A, including its $39 billion purchase of Nestlé S.A.'s 77% stake in Alcon Inc.and Novartis' proposal to purchase the remaining publicly-held stake of Alcon Inc. through a direct merger under Swiss law. She also has broad experience in emerging market transactions, including Novartis' pending $125 million acquisition of an 85% stake in Zheijiang Tianyuan Bio-Pharmaceuticals Co., Ltd, a vaccines company in China. Prior to joining Novartis, Ms. Sullivan was an associate at the London and New York offices of Allen & Overy LLP, where she specialized in equity and debt capital markets and M&A. She holds a J.D. from the University of Virginia School of Law, an M.Sc. in Comparative Politics from the London School of Economics and Political Science and a B.A. in Political Science from East Carolina University.

	Leigh Walton, Partner, Bass Berry & Sims, PLC Nashville, TN LEIGH WALTON is a member of the law firm of Bass, Berry & Sims PLC, where she co-chairs the firm's Health Law Practice Group and also concentrates her practice in corporate and securities law matters. She received her B.A. degree, magna cum laude, from Randolph-Macon Woman's College, Lynchburg, Virginia, and her J.D. degree from Vanderbilt University, where she was a member of Order of the Coif and the National Moot Court Team. She is active in the American, Tennessee and Nashville Bar Associations, serving as the Vice Chair of the ABA’s Committee on Mergers & Acquisitions (formerly Negotiated Acquisitions) and as a member of its Corporate Practice Committee. She is also serving as the Vice-Chair of AHLA's newly formed Transactions Affinity Group of the Business Law and Governance Practice Group. She lectures annually at the ABA's Annual Mergers and Acquisitions Institute, the ABA's Emerging Issues in Healthcare Law Conference and the Northwestern University School of Law's Securities Regulation Institute. She participates from time to time in many other seminars and programs on corporate, securities and healthcare matters. She is a fellow of the Tennessee Bar Foundation and the American Bar Foundation. Ms. Walton serves on the Metropolitan Development and Housing Agency of Metropolitan Davidson County. Ms. Walton is listed in The International Who’s Who of Corporate Governance Lawyers, The International Who's Who of Mergers & Acquisitions, Who's Who in American Law, Mid-South Super Lawyers, The Best Lawyers in America®, Lawdragon 500 and as one of America’s Leading Lawyers in Business by Chambers USA. She has also been listed in the Nashville Business Journal’s Healthcare 100, Best of the Bar, Women of Influence in 2008 and most recently, Corporate Counsel Edition of Super Lawyers for Securities & Corporate Finance (2009).

	Bonnie Washington, Vice President, Avalere Health LLC Washington, DC Bonnie Washington, Vice President, provides clients with strategic policy advice on a wide range of issues including Medicare policy development, health reform, and commercial strategy. Bonnie has particular expertise in the Medicare prescription drug benefit, Medicare Advantage, and pharmaceutical and health plan issues. Prior to joining Avalere, Bonnie led health policy development efforts for Novartis Pharmaceuticals Corporation and Ovations, a UnitedHealth Group Company. Prior to her industry experience, Bonnie led the Office of Legislation at the Centers for Medicare & Medicaid Services, formerly known as the Health Care Financing Administration. Specifically, Bonnie advised and represented the CMS administrator on legislation and policy related to Medicare, Medicaid, and the State Children’s Health Insurance Program (SCHIP). She also represented the administration before members of Congress and congressional staff. Previously, Bonnie served as an analyst with the Office of Management and Budget (OMB), advising OMB and White House policy officials on Medicaid and SCHIP policy options. Bonnie holds a B.A. from Loyola College in Maryland and a M.Sc. from the London School of Economics.

	Caroline Young, President, Nashville Health Care Council (NHCC) Nashville, TN Caroline Young is the president of the Nashville Health Care Council, a Nashville, Tennessee-based health care industry association of more than 175 member organizations. In this capacity, she works with executives to foster the growth of Nashville’s health care industry and to further position Nashville as the nation's health care industry capital. Caroline joined the Council in 2004, serving as the organization’s vice president and the founding executive director of the Council’s Leadership Health Care initiative, a group dedicated to nurturing the talents of Nashville’s next generation of health care industry leaders. Prior to joining the Council, Caroline served as an account executive in the Health Care practice of the Ingram Group, a public affairs and government relations firm. She was also founding executive director of the Tennessee Biotechnology Association and the director of communications and advertising for the Tennessee Department of Economic and Community Development (ECD). Caroline holds a M.S. from the University of Tennessee, Knoxville, and a B.A. from the University of Mississippi. A Nashville native, Caroline is a member of the U.S. Women Business Leaders in Health Care, and she currently serves on the boards of such organizations as the Friends of Vanderbilt Children’s Hospital, the Tennessee Biotechnology Association and Cumberland Emerging Technologies Advisory Board.

	Richard Zall, Member, Proskauer Rose LLP New York, NY Mr. Zall is a Partner at Proskauer Rose LLP and Chairman of its Health Care Department. His law practice is focused on the corporate and regulatory representation of a wide array of health care clients, including health care providers; information technology and medical device companies; managed care and health benefit management companies; and private equity firms. He also provides clients with counsel in the planning and execution of health care-related corporate transactions including mergers and acquisitions, and equity and debt financings; the structuring of joint ventures and other contractual relationships among various health industry parties; and compliance with federal and state health care laws and regulations. Mr. Zall is recognized as a leader in his field in Chambers USA, where he is described as, “a superstar, 100% focused on healthcare.” He was also named an “Outstanding Healthcare Transaction Lawyer” by Nightingale’s Healthcare News, one of the “Best Lawyers in America,” and one of “New York Area’s Best Lawyers” in New York Magazine. Mr. Zall received his J.D. from New York University School of Law in 1980, where he was a member of the Law Review and an Arthur Garfield Hays Fellow. He received a B.A. from Brown University in 1976.

	Mike Zuga, COO, Ambient Healthcare, Inc. Coral Springs, FL Mike Zuga is the Chief Operating Officer of Ambient Healthcare, Inc. In this capacity, Mike oversees the Operations of a $50 MM Home Infusion business located in the Southeast United States. Prior to his position as COO, Mike was the President and Co-Owner of Nutritional Parenteral Home Care, Inc (“NPHC”). NPHC was acquired by Ambient Healthcare in 2007. Mike attended The University of Alabama where he obtained a BS in Corporate Finance and Vanderbilt University for his MBA. While at Alabama, Mike played Football and was named to the Freshman All-American team in 1986.